Previous Article | Next Article 
Journal of Clinical Microbiology, May 1999, p. 1554-1560, Vol. 37, No. 5
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Evaluation of Recombinant Antigens for
Serodiagnosis of Chagas' Disease in South and Central
America
Eufrosina S.
Umezawa,1,*
Sueli F.
Bastos,1
Mario E.
Camargo,1
Luci M.
Yamauchi,2
Márcia R.
Santos,2
Antonio
Gonzalez,3
Bianca
Zingales,4
Mariano J.
Levin,5
Octavio
Sousa,6
Rafael
Rangel-Aldao,7 and
José Franco
da
Silveira2
Instituto de Medicina Tropical de São
Paulo, FMUSP,1 Departamento de Micro,
Imuno e Parasitologia da Escola Paulista de Medicina,
UNIFESP,2 and Instituto de
Química, USP,4 São Paulo, Brazil;
Instituto de Parasitologia y Biomedicina, CSIC, Granada,
Spain3; Instituto de Investigaciones en
Engenieria Genética y Biologia Molecular, Buenos Aires,
Argentina5; CIDEP, Universidad de
Panama, Panama6; and Universidad Simon
Bolivar, Caracas, Venezuela7
Received 26 October 1998/Returned for modification 5 January
1999/Accepted 2 February 1999
The commercially available diagnostic tests for Chagas' disease
employ whole extracts or semipurified fractions of
Trypanosoma cruzi epimastigotes. Considerable variation in
the reproducibility and reliability of these tests has been reported by
different research laboratories, mainly due to cross-reactivity with
other pathogens and standardization of the reagents. The use of
recombinant antigens for the serodiagnosis of Chagas' disease is
recommended to increase the sensitivity and specificity of serological
tests. Expressed in Escherichia coli, as fusion products
with glutathione S-transferase, six T. cruzi
recombinant antigens (H49, JL7, A13, B13, JL8, and 1F8) were evaluated
in an enzyme-linked immunosorbent assay for Chagas' disease. The study
was carried out with a panel of 541 serum samples of chagasic and
nonchagasic patients from nine countries of Latin America (Argentina,
Bolivia, Brazil, Chile, Colombia, El Salvador, Guatemala, Honduras, and
Venezuela). The optimal concentration of each recombinant antigen for
coating of plates was determined with the help of
125I-labelled recombinant proteins. While the specificity
of the epimastigote antigen was 84% because of false positives from
leishmaniasis cases, for the recombinant antigens it varied from 96.2 to 99.6%. Recombinant antigens reacted with 79 to 100% of serum
samples from chronic chagasic patients. In this way, it is proposed
that a mixture of a few T. cruzi recombinant antigens
should be employed in a diagnostic kit to minimize individual variation
and promote high sensitivity in the diagnosis of Chagas' disease.
*
Corresponding author. Mailing address: Instituto de
Medicina Tropical de São Paulo, FMUSP, Av. Dr. Enéas de
Carvalho Aguiar 470, CEP 05403-000, São Paulo, Brazil. Phone: 55 11 30 66 70 15. Fax: 55 11 852 36 22. E-mail:
eumezawa{at}usp.br.
Journal of Clinical Microbiology, May 1999, p. 1554-1560, Vol. 37, No. 5
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Camussone, C., Gonzalez, V., Belluzo, M. S., Pujato, N., Ribone, M. E., Lagier, C. M., Marcipar, I. S.
(2009). Comparison of Recombinant Trypanosoma cruzi Peptide Mixtures versus Multiepitope Chimeric Proteins as Sensitizing Antigens for Immunodiagnosis. CVI
16: 899-905
[Abstract]
[Full Text]
-
Houghton, R. L., Stevens, Y. Y., Hjerrild, K., Guderian, J., Okamoto, M., Kabir, M., Reed, S. G., Leiby, D. A., Morrow, W. J. W., Lorca, M., Raychaudhuri, S.
(2009). Lateral Flow Immunoassay for Diagnosis of Trypanosoma cruzi Infection with High Correlation to the Radioimmunoprecipitation Assay. CVI
16: 515-520
[Abstract]
[Full Text]
-
Verani, J. R., Seitz, A., Gilman, R. H., LaFuente, C., Galdos-Cardenas, G., Kawai, V., de LaFuente, E., Ferrufino, L., Bowman, N. M., Pinedo-Cancino, V., Levy, M. Z., Steurer, F., Todd, C. W., Kirchhoff, L. V., Cabrera, L., Verastegui, M., Bern, C.
(2009). Geographic Variation in the Sensitivity of Recombinant Antigen-based Rapid Tests for Chronic Trypanosoma cruzi Infection. Am J Trop Med Hyg
80: 410-415
[Abstract]
[Full Text]
-
Sanchez Negrette, O., Sanchez Valdez, F. J., Lacunza, C. D., Garcia Bustos, M. F., Mora, M. C., Uncos, A. D., Basombrio, M. A.
(2008). Serological Evaluation of Specific-Antibody Levels in Patients Treated for Chronic Chagas' Disease. CVI
15: 297-302
[Abstract]
[Full Text]
-
Aguirre, S., Silber, A. M., Brito, M. E. F., Ribone, M. E., Lagier, C. M., Marcipar, I. S.
(2006). Design, construction, and evaluation of a specific chimeric antigen to diagnose chagasic infection.. J. Clin. Microbiol.
44: 3768-3774
[Abstract]
[Full Text]
-
Marcipar, I. S., Roodveldt, C., Corradi, G., Cabeza, M. L., Brito, M. E. F., Winter, L. M. F., Marcipar, A. J., Silber, A. M.
(2005). Use of Full-Length Recombinant Calflagin and Its C Fragment for Improvement of Diagnosis of Trypanosoma cruzi Infection. J. Clin. Microbiol.
43: 5498-5503
[Abstract]
[Full Text]
-
Negrette, O. S., Mora, M. C., Basombrio, M. A.
(2005). High Prevalence of Congenital Trypanosoma cruzi Infection and Family Clustering in Salta, Argentina. Pediatrics
115: e668-e672
[Abstract]
[Full Text]
-
Lesenechal, M., Becquart, L., Lacoux, X., Ladaviere, L., Baida, R. C. P., Paranhos-Baccala, G., da Silveira, J. F.
(2005). Mapping of B-Cell Epitopes in a Trypanosoma cruzi Immunodominant Antigen Expressed in Natural Infections. CVI
12: 329-333
[Abstract]
[Full Text]
-
Umezawa, E. S., Luquetti, A. O., Levitus, G., Ponce, C., Ponce, E., Henriquez, D., Revollo, S., Espinoza, B., Sousa, O., Khan, B., da Silveira, J. F.
(2004). Serodiagnosis of Chronic and Acute Chagas' Disease with Trypanosoma cruzi Recombinant Proteins: Results of a Collaborative Study in Six Latin American Countries. J. Clin. Microbiol.
42: 449-452
[Abstract]
[Full Text]
-
Meira, W. S. F., Galvao, L. M. C., Gontijo, E. D., Machado-Coelho, G. L. L., Norris, K. A., Chiari, E.
(2002). Trypanosoma cruzi Recombinant Complement Regulatory Protein: a Novel Antigen for Use in an Enzyme-Linked Immunosorbent Assay for Diagnosis of Chagas' Disease. J. Clin. Microbiol.
40: 3735-3740
[Abstract]
[Full Text]
-
Di Noia, J. M., Buscaglia, C. A., De Marchi, C. R., Almeida, I. C., Frasch, A. C.C.
(2002). A Trypanosoma cruzi Small Surface Molecule Provides the First Immunological Evidence that Chagas' Disease Is Due to a Single Parasite Lineage. JEM
195: 401-413
[Abstract]
[Full Text]
-
Ciervo, A., Visca, P., Petrucca, A., Biasucci, L. M., Maseri, A., Cassone, A.
(2002). Antibodies to 60-Kilodalton Heat Shock Protein and Outer Membrane Protein 2 of Chlamydia pneumoniae in Patients with Coronary Heart Disease. CVI
9: 66-74
[Abstract]
[Full Text]
-
Ferreira, A. W., Belem, Z. R., Lemos, E. A., Reed, S. G., Campos-Neto, A.
(2001). Enzyme-Linked Immunosorbent Assay for Serological Diagnosis of Chagas' Disease Employing a Trypanosoma cruzi Recombinant Antigen That Consists of Four Different Peptides. J. Clin. Microbiol.
39: 4390-4395
[Abstract]
[Full Text]
-
Nakazawa, M., Rosa, D. S., Pereira, V. R. A., Moura, M. O., Furtado, V. C., Souza, W. V., Barros, M. D. N. D. S., Abath, F. G. C., Gomes, Y. M.
(2001). Excretory-Secretory Antigens of Trypanosoma cruzi Are Potentially Useful for Serodiagnosis of Chronic Chagas' Disease. CVI
8: 1024-1027
[Abstract]
[Full Text]
-
Saez-Alquézar, A., Sabino, E. C., Salles, N., Chamone, D. F., Hulstaert, F., Pottel, H., Stoops, E., Zrein, M.
(2000). Serological Confirmation of Chagas' Disease by a Recombinant and Peptide Antigen Line Immunoassay: INNO-LIA Chagas. J. Clin. Microbiol.
38: 851-854
[Abstract]
[Full Text]
-
Santos, M. R.M., Lorenzi, H., Porcile, P., Carmo, M. S. d., Schijman, A., Brandão, A., Araya, J. E., Gomes, H. B.M., Chiurillo, M. A., Ramirez, J. L., Degrave, W. M., Levin, M. J., da Silveira, J. F.
(1999). Physical Mapping of a 670-kb Region of Chromosomes XVI and XVII from the Human Protozoan Parasite Trypanosoma cruzi Encompassing the Genes for Two Immunodominant Antigens. Genome Res
9: 1268-1276
[Abstract]
[Full Text]